Chronic disease
Conditions
Interventions
Experimental group:R Plus health application
Control group:Follow up and patient education
Sponsors
Recovery Plus Inc
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: First study 1. Sub-health populations; 2. Aged between 18 and 75 years; 3. Own the ability to use smartphone; 4. Obtain the consent of the subject, family member, guardian or legal agent and sign the informed consent. Second study 1. Sub-health populations; 2. Chronic disease populations, e.g. individuals of hypertension, hyperlipemia, diabetes, obese/ overweight, cardiovascular disease, hyperuremia/gouty, breast cancers; 3. Aged between 18 and 75 years; 4. Own the ability to use smartphone; 5. Obtain the consent of the subject, family member, guardian or legal agent and sign the informed consent.
Exclusion criteria
Exclusion criteria: First study 1. Rate more than 3 out of 10 on the pain scale; 2. Poor compliance and no willing to cooperate with assessment, or exercised under heavy load; 3. A history of alcohol abuse or illegal drug use; 4. Pregnant women, lactating women or pregnant women (including male subjects); 5. Those who had participated in other clinical trials within three months before this trial. Second sturdy 1. Uncontrolled hypertension (resting blood pressure >= 160/100mmHg); uncontrolled diabetes (fasting glucose>7.1 mmol/l, HbA1C>7.0 %); 2. Organic disease e.g. unstable and severe cardiac disease, heart failure, unstable angina, myocardial infarction diagnosed by cardiologist; 3. Cerebrovascular accident occurred in past 6 months; 4. Patients with active gastrointestinal ulcer, thyroid dysfunction, active tuberculosis; 5. Chronic kidney disease >= 3 stages (eGFR < 60ml/min); 6. Received joints injection or surgery over lower extremities in past 6 months; 7. Poor compliance and have difficulties in cooperating with assessments and training; 8. Patients who cannot walk independently with assistive device; 9. Patients with psychological disease cannot live independently and cooperate with treatment; 10. A history of alcohol abuse or illegal drug use; 11. Pregnant women, lactating women or pregnant women (including male subjects); 12. Those who had participated in other clinical trials within three months before this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraclass correlation efficient, ICC;Cardiopulmonary fitness; | — |
Secondary
| Measure | Time frame |
|---|---|
| Muscle strength of upper extremities;Muscle strength of lower extremities;Muscle strength of abdominal muscles;Balance ability;Flexibility;Mobility;Compliance/ adherence;Safety; | — |
Countries
China
Contacts
Public ContactLin Yiyi
Shukang Clinic
Outcome results
None listed